Privigen globulin, immune
Ended Awarded
- Contract number
- 36C24819N0736
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $99,054
Award facts
- Contract value 100% obligated
- $99,053.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, valued at $99,053.50, was issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company. The contract is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), with a ceiling value of $201,482,280 through September 2026. The contract provides for the delivery of PRIVIGEN GLOBULIN, IMMUNE, a plasma-derived pharmaceutical product, to VA medical facilities nationwide. This contract does not have a set-aside designation, reflecting CSL Behring's status as a large, foreign-owned enterprise. The contract supports the VA's healthcare programs for veterans, enabling efficient procurement of critical medications through pre-negotiated pricing and terms.
Quick answers
Who was awarded contract 36C24819N0736?
36C24819N0736 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 8 (Veterans Health Administration) on May 2, 2019.
How much is contract 36C24819N0736 worth?
The government has obligated $99,054 on 36C24819N0736.
Is contract 36C24819N0736 an order under another contract?
Yes. 36C24819N0736 is a BPA call under V797D50358-VA24816A0004, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24819N0736 competed?
The extent of competition for 36C24819N0736 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award